215 related articles for article (PubMed ID: 30578500)
21. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.
Fujinami K; Lois N; Mukherjee R; McBain VA; Tsunoda K; Tsubota K; Stone EM; Fitzke FW; Bunce C; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8181-90. PubMed ID: 24265018
[TBL] [Abstract][Full Text] [Related]
22. Stargardt-Fundus flavimaculatus: recent advancements and treatment.
Haji Abdollahi S; Hirose T
Semin Ophthalmol; 2013; 28(5-6):372-6. PubMed ID: 24138045
[TBL] [Abstract][Full Text] [Related]
23. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.
Testa F; Rossi S; Sodi A; Passerini I; Di Iorio V; Della Corte M; Banfi S; Surace EM; Menchini U; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4409-15. PubMed ID: 22661472
[TBL] [Abstract][Full Text] [Related]
24. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
[TBL] [Abstract][Full Text] [Related]
25. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
[TBL] [Abstract][Full Text] [Related]
26. Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology.
Charbel Issa P; Barnard AR; Singh MS; Carter E; Jiang Z; Radu RA; Schraermeyer U; MacLaren RE
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5602-12. PubMed ID: 23761084
[TBL] [Abstract][Full Text] [Related]
27. Asymmetric Inter-Eye Progression in Stargardt Disease.
Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
[TBL] [Abstract][Full Text] [Related]
28. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time.
Cukras CA; Wong WT; Caruso R; Cunningham D; Zein W; Sieving PA
Arch Ophthalmol; 2012 Feb; 130(2):171-9. PubMed ID: 21987580
[TBL] [Abstract][Full Text] [Related]
29. G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull's eye maculopathy.
Cella W; Greenstein VC; Zernant-Rajang J; Smith TR; Barile G; Allikmets R; Tsang SH
Exp Eye Res; 2009 Jun; 89(1):16-24. PubMed ID: 19217903
[TBL] [Abstract][Full Text] [Related]
30. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
[TBL] [Abstract][Full Text] [Related]
31. Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus.
Oh KT; Weleber RG; Stone EM; Oh DM; Rosenow J; Billingslea AM
Retina; 2004 Dec; 24(6):920-8. PubMed ID: 15579991
[TBL] [Abstract][Full Text] [Related]
32. Peripapillary dark choroid ring as a helpful diagnostic sign in advanced stargardt disease.
Jayasundera T; Rhoades W; Branham K; Niziol LM; Musch DC; Heckenlively JR
Am J Ophthalmol; 2010 Apr; 149(4):656-660.e2. PubMed ID: 20138608
[TBL] [Abstract][Full Text] [Related]
33. ATP-binding cassette subfamily A, member 4 intronic variants c.4773+3A>G and c.5461-10T>C cause Stargardt disease due to defective splicing.
Jonsson F; Westin IM; Österman L; Sandgren O; Burstedt M; Holmberg M; Golovleva I
Acta Ophthalmol; 2018 Nov; 96(7):737-743. PubMed ID: 29461686
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence in Stargardt Disease.
Greenstein VC; Nunez J; Lee W; Schuerch K; Fortune B; Tsang SH; Allikmets R; Sparrow JR; Hood DC
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5227-5236. PubMed ID: 29049723
[TBL] [Abstract][Full Text] [Related]
35. En face OCT in Stargardt disease.
Sodi A; Mucciolo DP; Cipollini F; Murro V; Caporossi O; Virgili G; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1669-79. PubMed ID: 26743751
[TBL] [Abstract][Full Text] [Related]
36. The external limiting membrane in early-onset Stargardt disease.
Lee W; Nõupuu K; Oll M; Duncker T; Burke T; Zernant J; Bearelly S; Tsang SH; Sparrow JR; Allikmets R
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6139-49. PubMed ID: 25139735
[TBL] [Abstract][Full Text] [Related]
37. The dark atrophy with indocyanine green angiography in Stargardt disease.
Giani A; Pellegrini M; Carini E; Peroglio Deiro A; Bottoni F; Staurenghi G
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3999-4004. PubMed ID: 22589445
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Fundus Autofluorescence and Optical Coherence Tomography in PRPH2/RDS- and ABCA4-Associated Disease Exhibiting Phenotypic Overlap.
Duncker T; Tsang SH; Woods RL; Lee W; Zernant J; Allikmets R; Delori FC; Sparrow JR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3159-70. PubMed ID: 26024099
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Fundus Autofluorescence in ABCA4-Related Retinopathy -Functional Relevance and Genotype-Phenotype Correlation.
Müller PL; Gliem M; McGuinnes M; Birtel J; Holz FG; Charbel Issa P
Am J Ophthalmol; 2021 Feb; 222():340-350. PubMed ID: 32891696
[TBL] [Abstract][Full Text] [Related]
40. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
